Denali Therapeutics Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2016 | $0 | $-87.4M | $-86.7M |
| FY2017 | $0 | $-90.1M | $-88.2M |
| FY2018 | $129.2M | $-46.4M | $-36.2M |
| FY2019 | $26.7M | $-213.2M | $-197.6M |
| FY2020 | $335.7M | $62.7M | $71.1M |
| FY2021 | $48.7M | $-295.8M | $-290.6M |
| FY2022 | $108.5M | $-340.7M | $-326.0M |
| FY2023 | $330.5M | $-196.7M | $-145.2M |
| FY2024 | $0 | $-487.3M | $-422.8M |
| FY2025 | $0 | $-555.3M | $-512.5M |